Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

Advances in the Role of Adipose Tissue in Promoting Injury Repair and Resist Infection.

Duan X., Li R., Fu L., Yang J., Zhan Z.

Narrative Review on Chronic Wound, Scar, Immune Modulation, published in Immun Inflamm Dis (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Immun Inflamm Dis (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41640028
PMCID
PMC12872982
DOI
10.1002/iid3.70341
Citations
3

Abstract (original English)

Adipose tissue (AT) transplantation has emerged as a critical therapeutic strategy for tissue restoration and regeneration in recent years. Accumulating evidence demonstrates that AT exerts dual functions in promoting tissue repair and conferring anti-infective properties, with distinct biological effects attributed to its heterogeneous components. This review systematically examines the distribution of AT in different populations and the components of AT, including adipocytes, extracellular matrix (ECM), immune cells, stromal vascular fraction (SVF), and adipokines. Distinct AT components mediate tissue repair and infection resistance through unique molecular mechanisms. Functionally, adipocytes coordinate with macrophages during wound healing by secreting immunomodulatory adipokines—including adiponectin, leptin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and antimicrobial peptides (AMPs)—that orchestrate inflammatory signaling and enhance host defense mechanisms. ECM provides structural support while releasing cytokines that synergistically enhance angiogenesis and tissue remodeling. SVF cell populations exhibit dual functionality: accelerating neural and cutaneous regeneration while suppressing fibrotic pathways to minimize scar formation. Finally, recommendations are proposed to guide future investigations into AT-mediated immune functions. This review highligh

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAdipose TissueWound HealingAnimalsExtracellular MatrixAdipocytesInfectionsAdipokinesRegenerationCytokines

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research